See More Hear More Watch More Hear More Get on iTunes
StrictlyVC StrictlyVC

LifeBond Raises Half of Series D Round

LifeBond, a seven-year-old, Caesarea, Israel-based company in clinical trials with biocompatible devices for tissue repair, has raised roughly half of a $25 million Series D round, reports VentureWire.


More from